The financial results were subjected to a limited review by the statutory auditors, S.R. Batliboi & Co. LLP (ICAI Firm Registration Number: 301003E/E300005), who issued an unmodified conclusion, stating that nothing has come to their attention to believe the statement contains any material misstatement. The review was conducted by Partner Sandy Kumar Agarwal (Membership No.: 060352).

The results will be published in a newspaper as required by Regulation 47 and uploaded on the company's website, www.ilshospitals.com.

Financial Performance (Quarterly Comparison)

All figures are in ₹ lakhs.

Total Income:

  • Q1 FY27 (Jun 30, 2026): ₹12,823.04
  • Q4 FY26 (Mar 31, 2026): ₹12,800.02 (Audited)
  • Q1 FY26 (Jun 30, 2025): ₹10,867.16

Revenue from Operations:

  • Q1 FY27: ₹12,620.43
  • Q4 FY26: ₹12,637.18
  • Q1 FY26: ₹10,710.86

Other Income:

  • Q1 FY27: ₹202.61
  • Q4 FY26: ₹162.84
  • Q1 FY26: ₹156.30

Total Expenses:

  • Q1 FY27: ₹11,106.57
  • Q4 FY26: ₹11,213.54
  • Q1 FY26: ₹9,755.80

Breakdown of Expenses:

  • Cost of materials consumed: Q1 FY27: ₹2,414.86; Q4 FY26: ₹2,340.14; Q1 FY26: ₹2,067.28
  • Employee benefits expense: Q1 FY27: ₹2,323.69; Q4 FY26: ₹2,221.27; Q1 FY26: ₹2,042.04
  • Finance costs: Q1 FY27: ₹216.27; Q4 FY26: ₹218.18; Q1 FY26: ₹163.28
  • Depreciation and amortisation: Q1 FY27: ₹688.09; Q4 FY26: ₹694.91; Q1 FY26: ₹618.16
  • Other expenses: Q1 FY27: ₹5,463.66; Q4 FY26: ₹5,739.04; Q1 FY26: ₹4,865.04

Profit Before Tax (PBT):

  • Q1 FY27: ₹1,716.47
  • Q4 FY26: ₹1,586.48
  • Q1 FY26: ₹1,111.36

Tax Expense:

  • Q1 FY27: ₹443.33 (Current tax: ₹471.00; Deferred tax credit: ₹(27.67))
  • Q4 FY26: ₹129.88 (Current tax: ₹480.00; Deferred tax credit: ₹(350.12))
  • Q1 FY26: ₹343.18 (Current tax: ₹199.00; Deferred tax: ₹144.18)

Profit After Tax (PAT):

  • Q1 FY27: ₹1,273.14
  • Q4 FY26: ₹1,456.60
  • Q1 FY26: ₹768.18

Other Comprehensive Income/(Loss) (OCI):

  • Q1 FY27: ₹(1.26) [Remeasurement of defined benefit plan: ₹(1.68); Income tax relating to above: ₹0.42]
  • Q4 FY26: ₹(9.37) [Remeasurement of defined benefit plan: ₹(13.21); Income tax relating to above: ₹3.84]
  • Q1 FY26: ₹(1.19) [Remeasurement of defined benefit plan: ₹(1.68); Income tax relating to above: ₹0.49]

Total Comprehensive Income:

  • Q1 FY27: ₹1,271.88
  • Q4 FY26: ₹1,447.23
  • Q1 FY26: ₹766.99

Earnings Per Share (EPS) (face value of ₹10 each):

  • Q1 FY27: Basic ₹1.55; Diluted ₹1.55
  • Q4 FY26: Basic ₹1.78; Diluted ₹1.78
  • Q1 FY26: Basic ₹0.94; Diluted ₹0.94

Paid-up equity share capital: Remained unchanged at ₹8,205.48 lakhs.

Additional Notes from Financial Statement

1. The financial results were prepared in accordance with Indian Accounting Standards (Ind AS), specifically Ind AS 34.

2. The company operates in a single reportable business and geographical segment: healthcare services in India.

3. The company does not have any subsidiary, associate, or joint venture company as of June 30, 2026.

4. The figures for the quarter ended March 31, 2026, are the balancing figures between the audited full-year results and the previously published unaudited year-to-date figures up to December 31, 2025.

5. The EPS figures are not annualized.